An interventional study of Computer-Based Auditory Training and Clinician-Guided Auditory Training in Bilateral Hearing Loss, sponsored by NYU Langone Health. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by NYU Langone Health · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 30 studies in Hearing Loss, Bilateral with a site in United States — 12 open to participants now, 14 under way, 1 of them phase 3. Hearing Loss, Bilateral · United States.
Among the 30 studies in Hearing Loss, Bilateral with a site in United States, this one is the 7th largest by planned enrollment of the 25 interventional ones that give a count, is one of 3 that started in 2026, is one of 20 with no phase, reaches primary completion later than 10 of the 13 other live ones, and was the 30th registered.
55 studies on the registry are indexed under Hearing Loss, Bilateral; 17 are open to participants now.
Browse Hearing Loss, Bilateral studies →12 of the 30 studies in Hearing Loss, Bilateral with a site in United States are open now. Recruiting first, the newest first:
Skylark Bio Inc. · Sites in United States
Ages 9 mo–7 yrs
University of South Florida · Sites in United States
Ages 18–90 · Healthy volunteers
Vanderbilt University · Sites in United States
Ages 9–15
University of Alabama, Tuscaloosa · Sites in United States
Ages 18+ · Healthy volunteers
Cochlear · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 12 Hearing Loss, Bilateral studies recruiting now, 7 (58%) set no upper age limit and 3 (25%) stop at 75 or younger; 4 take children under 18; 2 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
30 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 4 · Phase 3 1
First in 2001; this study’s year is marked. 3 started in 2026.
This study's planned enrollment of 50 is above the median of 30 across 42 interventional studies indexed under Hearing Loss, Bilateral.
Median enrollment 35 across the 25 interventional studies, 67 across the 5 observational. Of the 16 that completed or were terminated, 12 (75%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 30 have an industry lead sponsor. The 10 most frequent:
NYU Langone Health is the lead sponsor of 1,431 studies on the registry; 259 are open to participants now.
Of its 235 completed or terminated interventional studies of FDA-regulated products, 197 (84%) have results posted.
NYU Langone Health has 1 study filed under Hearing Loss, Bilateral — fewer than ten, so there is no comparison to draw.
4 of the studies in Hearing Loss, Bilateral with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06860022Vanderbilt UniversitySentence Shaping - DHH | 2026-11 |
| NCT04707885Ohio State UniversityClinical Utility of Residual Hearing in the Cochlear Implant Ear | 2026-12-31 |
| NCT07081542AdventHealthComparative Analysis of Hearing Outcomes: Robotic vs. Manual Insertion of Cochlear Implants | 2027-01-31 |
| NCT06864273University of Alabama, TuscaloosaAssessing Pharmacy Technician Educational Training for the Provision of Over-the-Counter Hearing Aids in Rural Alabama and Mississippi Pharmacies | 2027-08-31 |
Add all 4 to your calendar (.ics) → With an account.
Among the 30 studies in Hearing Loss, Bilateral with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will compare two different types of aural rehabilitation schedules (computer-based auditory training vs computer based auditory training and clinician guided training) for adult cochlear implant (CI) users to determine the effect of rehabilitation type on speech perception, hearing related-quality of life, and CI management skills.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
CI users assigned to receive computer-based auditory training only.
Behavioral: Computer-Based Auditory Training
CI users assigned to receive computer-based auditory training and clinician-guided training.
Behavioral: Computer-Based Auditory Training · Behavioral: Clinician-Guided Auditory Training
Aural rehabilitation program delivered through an auditory training app. Each participant will be assigned to complete training 5 days per week, with each session being 15 minutes for the first 6 months post-activation.
Aural rehabilitation program delivered by a speech-language pathologist.
Change in CNC Word Recognition Score
Calculated as the percentage of words a person can hear, repeat back, and understand.
Time frame: Baseline (pre-cochlear implant), Year 1 Post-Activation
Change in CNC Phoneme Recognition Score
Calculated as the percentage of individual phonemes (sounds) identified correctly out of 150 total phonemes.
Time frame: Baseline (pre-cochlear implant), Year 1 Post-Activation
Change in AzBio Sentence Recognition Score
Standardized speech perception assessment used by audiologists to measure how well a person understands everyday conversational speech. Patients are evaluated on their ability to recognize words correctly in a sentence. Each sentence has a set number of key words assigned specific point values. The final score is calculated as a percentage of words correct out of the total possible words in the list.
Time frame: Baseline (pre-cochlear implant), Year 1 Post-Activation
Change in CIQOL35 Profile Score
Patient-reported outcome measure designed to evaluate real-world functional abilities and quality of life for adult cochlear implant (CI) users. Each item is rated on a Likert scale; the raw score is re-scaled into a total score from 0 (low quality of life/functional ability) to 100 (high quality of life/functional ability).
Time frame: Week 6 Post-Activation, Year 1 Post-Activation
Change in CIMS-Self
10-item self-administered assessment of how effectively a patient or caregiver handles and maintains a cochlear implant processor. Each response is rated from 0 to 3; the raw score is the sum of responses and is transformed to a percentage (0 - 100%); a score below 100% indicates a need for targeted training or retraining in specific maintenance areas.
Time frame: Week 6 Post-Activation, Year 1 Post-Activation
Plan to share: No — No plan to make IPD available.
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Jan 2029, 25 months later.
Of 27 interventional studies with no phase under Hearing Loss, Bilateral, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 60. This study's planned 25 months is above that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.